v3.26.3
Share-Based Payment Arrangements (Tables)
9 Months Ended
Sep. 26, 2026
Share Based Payment Arrangements [Line Items]  
Schedule of Amounts Recognized in Financial Statements with Respect to Plans Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):
 
     Thirty-Nine Weeks Ended      Thirteen Weeks Ended  
     September 26,
2026
     September 27,
2025
     September 26,
2026
     September 27,
2025
 
Total cost of the Plans during the period
   $ 8,443      $ 5,243      $ 3,023      $ 1,586  
Amount of related income tax benefit recognized during the period
     (2,082 )       (1,179 )       (741 )       (387 ) 
  
 
 
    
 
 
    
 
 
    
 
 
 
Net cost of the Plans during the period
   $ 6,361      $ 4,064      $ 2,282      $ 1,199  
  
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of Information on Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:
 
     Number of
RSUs
     Weighted Average
Grant Date
Fair Value
 
Outstanding at December 27, 2025
     203,712      $ 143.95  
Granted
     65,401      $ 134.55  
Forfeited
     (45,208 )     $ 154.76  
  
 
 
    
Outstanding at September 26, 2026
     223,905      $ 139.02  
  
 
 
    
Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of non-vested restricted stock and Deferred Stock Units (defined below) under the Plans:
 
     Number of Shares
and Deferred
Stock Units
     Weighted Average
Grant Date
Fair Value
 
Non-vested at December 27, 2025
     53,776      $ 168.95  
Granted
     41,059      $ 157.79  
Vested
     (31,570 )     $ 167.44  
Forfeited
     (4,615 )     $ 164.59  
  
 
 
    
Non-vested at September 26, 2026
     58,650      $ 162.29